2:40 PM
 | 
Jul 10, 2018
 |  BC Extra  |  Preclinical News

Models could help predict AML risk

In a Nature paper, a team led by researchers at University Health Network and Wellcome Sanger Institute developed two models to predict healthy subjects’ likelihood for developing acute myelogenous leukemia that could provide the basis for an AML risk diagnostic.

The first method was based on recurrent mutations in genes...

Read the full 232 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >